Prot #NU 15C01: Phase I/II trial of Radiation Therapy plus Temozolomide with MK-3475 in patients with newly diagnosed Glioblastoma (GBM)

  • Dixit, Karan (PD/PI)
  • Raizer, Jeffrey J (PD/PI)
  • Raizer, Jeffrey J (Other)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/15/15 → 9/15/22

Funding

  • Merck Sharp & Dohme Corporation (Prot #NU 15C01)